The cancer supportive care drugs global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Cancer Supportive Care Drugs Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The cancer supportive care drugs market size has grown steadily in recent years. It will grow from $19.93 billion in 2023 to $20.83 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to rising geriatric population, increasing prevalence of chemotherapy, growing demand for antiemetics, growing preference for online pharmacies and drug stores, increasing awareness of supportive care, increasing adoption of personalized medicine, growing emphasis on palliative care.
The cancer supportive care drugs market size is expected to see grown steadily in the next few years. It will grow to $24.97 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to rising awareness about adverse effects of cancer treatment, growing cases of breast cancer among females, the availability of specific medication plans, demand for online doctor consultations, an improved supply chain in the pharmaceutical sector, increasing the population of cancer survivors. Major trends in the forecast period include advancements in targeted therapies, integration of biobehavioral interventions, implementation of survivorship care plans, integration of nutritional support, advancements in pain management strategies, implementation of symptom monitoring platforms.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-drugs-global-market-report
Scope Of Cancer Supportive Care Drugs Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Cancer Supportive Care Drugs Market Overview
Market Drivers -
The cancer supportive care drugs market size has grown steadily in recent years. It will grow from $19.93 billion in 2023 to $20.83 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to rising geriatric population, increasing prevalence of chemotherapy, growing demand for antiemetics, growing preference for online pharmacies and drug stores, increasing awareness of supportive care, increasing adoption of personalized medicine, growing emphasis on palliative care.
The cancer supportive care drugs market size is expected to see grown steadily in the next few years. It will grow to $24.97 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to rising awareness about adverse effects of cancer treatment, growing cases of breast cancer among females, the availability of specific medication plans, demand for online doctor consultations, an improved supply chain in the pharmaceutical sector, increasing the population of cancer survivors. Major trends in the forecast period include advancements in targeted therapies, integration of biobehavioral interventions, implementation of survivorship care plans, integration of nutritional support, advancements in pain management strategies, implementation of symptom monitoring platforms.
Market Trends -
Major companies operating in the cancer support care drugs market are developing combination therapies to address the complexity and challenges of cancer treatment. Combination therapies involve the strategic use of two or more therapeutic agents to target different aspects of cancer growth and survival, aiming to achieve deeper and more durable responses compared to monotherapy. For instance, in November 2023, Merck, a US-based pharmaceutical company received approval from the Food and Drug Administration, a US-based federal agency, for KEYTRUDA, an anti-PD-1 therapy, in combination with gemcitabine and cisplatin, for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer (BTC). The combination therapy showed promising results in improving overall survival and providing a new treatment option for patients with this challenging condition.
The cancer supportive care drugs market covered in this report is segmented –
1) By Type: Erythropoiesis Stimulating Agents, Granulocyte Colony Stimulating Factors, Antiemetics, Bisphosphonates, Opioids, Nonsteroidal Anti Inflammatory Drugs, Other Types
2) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Other Channels
Get an inside scoop of the cancer supportive care drugs market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15749&type=smp
Regional Insights -
North America was the largest region in the cancer supportive care drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies -
Major companies operating in the cancer support care drugs market are developing combination therapies to address the complexity and challenges of cancer treatment. Combination therapies involve the strategic use of two or more therapeutic agents to target different aspects of cancer growth and survival, aiming to achieve deeper and more durable responses compared to monotherapy. For instance, in November 2023, Merck, a US-based pharmaceutical company received approval from the Food and Drug Administration, a US-based federal agency, for KEYTRUDA, an anti-PD-1 therapy, in combination with gemcitabine and cisplatin, for the treatment of patients with locally advanced unresectable or metastatic biliary tract cancer (BTC). The combination therapy showed promising results in improving overall survival and providing a new treatment option for patients with this challenging condition.
Table of Contents
1. Executive Summary
2. Cancer Supportive Care Drugs Market Characteristics
3. Cancer Supportive Care Drugs Market Trends And Strategies
4. Cancer Supportive Care Drugs Market - Macro Economic Scenario
5. Global Cancer Supportive Care Drugs Market Size and Growth
.
.
.
32. Global Cancer Supportive Care Drugs Market Competitive Benchmarking
33. Global Cancer Supportive Care Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cancer Supportive Care Drugs Market
35. Cancer Supportive Care Drugs Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The newly added Cancer Supportive Care Drugs market research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2027.
Basically, this report is designed to give a proper understanding of industry structure and competition intensity attractiveness.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the cancer supportive care drugs market include Amgen Inc., Merck & Co., Johnson & Johnson SeRvices, Inc., Heron Theovartis, Novartis AG, Tesaro, Inc., F. Hoffmann-La Roche AG, Helsinn Healthcare SA, Teva Pharmaceuticals, 3SBio, BioSidus.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Cancer Supportive Care Drugs Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/cancer-supportive-care-drugs-market/download-sampleMarket DynamicsThe increasing prevalence of cancer globally and many side effects associated with cancer treatment are the major factors driving the cancer supportive care drug market over the forecast time frame.
In addition to that, increasing uptake of biosimilars and the availability of effective treatment methods are other factors that add fuel to the growth of the cancer supportive care drugs market.
Moreover, the technological advancements in targeted therapy drugs, which have lesser side effects than traditional cancer therapy drugs, is anticipated to give rise to more demand in the coming years.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
Cancer supportive care drugs market Increased survival and quality of life is improved by using supportive care which is used in mitigation of various types of malignancy.
Cancer supportive care is focused on relieving patients from adverse effects of cancer therapies as well as treatments.
The side effects of cancer treatment include poor appetite, nausea, vomiting and anaemia.
The Multinational Association for Supportive Care in cancer has created a scoring index for identifying the low-risk febrile neutropenia patients.Cancer supportive care drugs market is expected to at steady CAGR of 2.1% in the forecast period of 2019-2026.
The report contains data of the base year 2018 and historic year 2017.
Growing consumption of biosimilar drugs is augmenting the growth of the market.This Cancer Supportive Care Drugs Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.
